You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Anion Exchange Resins for Chirality-based Separation of Single-wall Carbon Nanotubes
SBC: Sepax Technologies, Inc. Topic: 9060663RSingle chirality of single-walled carbon nanotubes (SWCNTs) is critical for their superb mechanical, thermal, optical and electronic properties. All known methods for producing nanotubes give mixtures of tubes with different chiralities. Physical separation of SWCNT by chirality is thus an enabling step for many potential applications and fundamental studies. The existing anion exchange resins are ...
SBIR Phase I 2011 Department of CommerceNational Institute of Standards and Technology -
SBIR Phase I: Rapid Self-Decontaminating Textiles
SBC: WARWICK MILLS INC Topic: BCThis Small Business Innovation Research (SBIR) Phase I project proposes to develop advanced antiseptic textiles to be used in garments to prevent cross contamination of antibiotic-resistant pathogens. Drug-resistant pathogens Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Staphylococcus aureus (VRSA), and Clostridium difficile represent a significant public health problem ...
SBIR Phase I 2011 National Science Foundation -
SBIR Phase I: An Icosadedral Robotic Motion Cell
SBC: Square One Systems Design, Inc. Topic: ICThis Small Business Innovation Research Phase I project addresses a new approach to robotic mobility. Over the past decade, robots have become an increasingly important component of human existence. While the introduction of mobility technologies have allowed robots to migrate from manufacturing assignments out into the wider world, the vast majority of mobile robots rely solely on wheeled locomot ...
SBIR Phase I 2011 National Science Foundation -
SBIR Phase I: Biocatalysts for the Production of Itaconinc Acid
SBC: Itaconix Corporation Topic: BCThis Small Business Innovation Research Phase I project brings together a cross-disciplinary team of chemical engineers and biochemists from academia and industry to demonstrate the feasibility of manufacturing the renewable monomer, itaconic acid (IA) through heterogeneous catalysis. Presently, IA is produced commercially (15,000 tons/yr) by a lengthy (>4 day) fermentation of glucose by Aspergill ...
SBIR Phase I 2011 National Science Foundation -
VISTA: A Novel Therapeutic Target That Negatively Regulates Immunity
SBC: IMMURX LLC Topic: NIAIDDESCRIPTION (provided by applicant): We have discovered, characterized and functionally defined a novel, immune inhibitory ligand. This ligand is hematopoietically-expressed, a distant member of the B7 Ig-superfamily, and its extracellular domain bears homology to the B7 family ligand PD-L1. This molecule is designated as V-domain Immunoglobulin Suppressor of T cell Activation (VISTA). Distinct fr ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Scleroderma Subtyping from Fresh and Archived Biopsies using NextGen Sequencing
SBC: CELDARA MEDICAL, LLC Topic: NIAMSDESCRIPTION (provided by applicant): Systemic sclerosis (SSc) is an autoimmune disease that presents with a heterogeneous and complex phenotype. Major manifestations of the disease are skin fibrosis, vascular dysfunction, and immune system activation. There are no validated diagnostic markers. There are no curative treatments. One in three patients dies within 10 years of diagnosis. Some drugs (de ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies
SBC: Woomera Therapeutics, Inc. Topic: NCIDESCRIPTION (provided by applicant): The objective of this Phase 1 project is to improve an effective treatment of recurrent small-cell lung cancer (rSCLC) by targeting a tumor-specific abnormal receptor, AbnV2 that is a surface-marker of the disease. Currently, there is no effective treatment for rSCLC. Our data show expression of this abnormal vasopressin V2 receptor (AbnV2 ) is a common featur ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Novel Catalyst Systems
SBC: COMPACT MEMBRANE SYSTEMS, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Transition metal catalysts are widely used in the pharmaceutical industry for the production of active ingredients, precursors and new drug candidates. These products must be very pure, often requiring labor and energyintensive separation processes, to achieve the required purity levels. Of special concern in the present context is to avoid contaminating the pr ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Customized Nanofiltration Membranes for Enhancing Pharmaceutical Manufacturing
SBC: COMPACT MEMBRANE SYSTEMS, INC. Topic: NIGMSDESCRIPTION (provided by applicant): The overall focus of this application is to develop nanofiltration membranes to recover the spent solvents generated from drug manufacturing processes allowing the solvents to be reused resulting in elimination of waste. This is also responsive to NIH RFP PA-09-100 entitled Energy Efficiency and Renewable Energy System Technology Research and Development . By ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Novel Materials and Methods for Separations of Glycopeptides and Glycans
SBC: ADVANCED MATERIALS TECHNOLOGY, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Analysis of glycoprotein polypeptide sites of carbohydrate attachment and the structures of the glycans present on these proteins requires the combination of high resolution chromatographic separations and sophisticatedmass spectrometry. Hydrophilic interaction liquid chromatography (HILIC) has great use in separations of glycopeptides and released glycans, exh ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health